California Public Employees Retirement System Bei Gene, Ltd. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$121.11 - $216.05 $10.9 Million - $19.4 Million	-89,908 Reduced 44.96%	110,059 $17.8 Million
Q1 2022 May 04, 2022	SELL	$146.52 - $269.56 $3.03 Million - $5.57 Million	-20,668 Reduced 9.37%	199,967 $37.7 Million
Q4 2021 Feb 10, 2022	BUY	$248.56 - $389.34 $767,553 - $1.2 Million	3,088 Added 1.42%	220,635 $59.8 Million
Q3 2021 Nov 10, 2021	BUY	$249.6 - $403.14 $1.06 Million - $1.71 Million	4,242 Added 1.99%	217,547 $79 Million
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $2.21 Million - $2.77 Million	7,536 Added 3.66%	213,305 $73.2 Million
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $53.6 Million - $78.6 Million	205,769 New	205,769 $71.6 Million
Q4 2020 Feb 02, 2021	SELL	$221.31 - $316.61 $53.2 Million - $76.1 Million	-240,287 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$189.18 - $286.44 $20.5 Million - $31 Million	108,324 Added 82.09%	240,287 $68.8 Million
Q2 2020 Aug 12, 2020	BUY	$123.9 - $195.41 $6.69 Million - $10.6 Million	53,997 Added 69.26%	131,963 $24.9 Million
Q1 2020 May 12, 2020	BUY	$121.84 - $173.19 $114,651 - $162,971	941 Added 1.22%	77,966 $9.6 Million
Q4 2019 Jan 27, 2020	BUY	$115.78 - $208.34 $1.58 Million - $2.84 Million	13,640 Added 21.52%	77,025 $12.8 Million
Q3 2019 Oct 31, 2019	BUY	$120.61 - $148.29 $5 Million - $6.15 Million	41,488 Added 189.47%	63,385 $7.76 Million
Q2 2019 Aug 15, 2019	SELL	$113.99 - $146.86 $268,332 - $345,708	-2,354 Reduced 9.71%	21,897 $2.71 Million
Q1 2019 May 03, 2019	SELL	$122.82 - $151.83 $1.96 Million - $2.42 Million	-15,923 Reduced 39.64%	24,251 $3.2 Million
Q4 2018 Feb 08, 2019	SELL	$107.01 - $175.15 $1.38 Million - $2.26 Million	-12,898 Reduced 24.3%	40,174 $5.64 Million
Q3 2018 Nov 13, 2018	BUY	$152.62 - $189.66 $2.58 Million - $3.2 Million	16,893 Added 46.69%	53,072 $9.14 Million
Q2 2018 Aug 15, 2018	SELL	$152.5 - $216.77 $3.36 Million - $4.78 Million	-22,043 Reduced 37.86%	36,179 $5.56 Million
Q1 2018 May 11, 2018	BUY	$97.41 - $177.22 $1.08 Million - $1.96 Million	11,083 Added 23.51%	58,222 $9.78 Million
Q4 2017 Feb 06, 2018	SELL	$79.6 - $114.73 $27,302 - $39,352	-343 Reduced 0.72%	47,139 $4.61 Million
Q3 2017 Nov 15, 2017	BUY	$66.19 - $103.46 $3.14 Million - $4.91 Million	47,482	47,482 $4.91 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.89 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.15 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$927 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$891 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$664 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account